Johnson & Johnson (JNJ) Debt to Equity (2009 - 2026)

Johnson & Johnson has disclosed Debt to Equity across 18 years of filings, most recently posting $0.68 for Q1 2026.

• Debt to Equity for Q1 2026 came in at $0.68, up 1.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.68 (up 1.25% YoY), and the FY2025 annual result was $0.59, up 14.71% from the prior year.
• Debt to Equity came in at $0.68 for Q1 2026 at Johnson & Johnson, up from $0.59 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.75 in Q2 2023 to a low of $0.42 in Q4 2023.
• The 5-year median for Debt to Equity is $0.51 (2024), against an average of $0.54.
• Across the five-year window, Debt to Equity soared 68.26% in 2023 and slumped 35.66% in 2024, its largest moves.
• Johnson & Johnson's Debt to Equity stood at $0.43 in 2022, then decreased by 0.66% to $0.43 in 2023, then grew by 20.15% to $0.51 in 2024, then increased by 14.71% to $0.59 in 2025, then gained by 15.22% to $0.68 in 2026.
• The last three Debt to Equity figures came in at $0.68 (Q1 2026), $0.59 (Q4 2025), and $0.58 (Q3 2025), per Business Quant data.